In this EOSC-Life workshop “Sharing sensitive data – centralised, federated or hybrid?”, we will examine the pros and cons of data sharing approaches by taking a look at specific use cases in the life sciences domain.
While great progress has been made in recent years in the development of public health within the European Union (EU), the Covid-19 pandemic brought to light existing vulnerabilities in the European health response mechanism, from Member State incoordination to difficulties in manufacturing and accessing medicines, to EU research fragmentation and differences between corporate R&D choices and public health priorities.
For the first time in two years, ICPerMed is delighted to organise a physical meeting and to welcome you in Paris on October 5-6, 2022 for the ICPerMed Conference – Prelude to the Future of Medicine.
The drug repurposing field has shifted after stepping into the limelight during the global COVID-19 pandemic. The world is beginning to care about drug repurposing and is recognising the opportunities to repurpose a drug to treat an often rare and neglected condition.
Repurposing schemes, projects and ideas are all in place to accelerate access to desperately needed medicines - the answers have been right under our noses all along!
EU-AMRI is organising a one-hour side event at ICRI 2022, held in Brno (Czech Republic). With actual case scenarios in the field of scientific health research, EU-AMRI wants to shine a light on national and international collaborations creating synergies between Research Infrastructures.
On 15 and 16 November 2022 the 4th EULAC PerMed Summer School will take place as a hybrid event, held in Panama City (Panama) and broadcasted online as well. The EULAC PerMed Summer School on clinical studies in Personalised Medicine aims for junior researchers and personalised medicine stakeholders, and has a specific focus on illustrating clinical studies’ gaps and challenges under different disease perspectives: infectious and neglected diseases, oncology diseases, cardiovascular and rare diseases.
On 17 and 18 November 2022 EULAC PerMed organises the third and final technical workshop on clinical trials in Personalised Medicine. The workshop will focus on the clinical trial designs applied in Personalised Medicine, exploring the advantages and challenges of the different designs through use cases. The workshop will also address the challenges and opportunities of multinational collaborations in Personalised Medicine.
ECRIN will host its 2nd CTU Day from 10-13h on 2 December 2022. The event is open to members of ECRIN national partner networks.
The program is in the process of finalisation but this years event will include feedback on the use of CTIS for multinational trials.
Stay tuned for registration and more program details
Together with EMA, ECRIN will co-host a session 3 December 2021 (9:00-13:00 CET) to support academic organisations as they look to implement CTIS. This event is developed for the ECRIN CTU community and it will include live demonstrations and Q&A to address your most pressing questions as the CTIS launch approaches. This is a free event.
The EU-Africa PerMed project funded by the European Commission's H2020 framework programme seeks to develop international collaborations and identify future actions in personalised medicine to be established between Africa and Europe. The objective is to build a lasting relationship between these two continents in terms of research, development, innovation and implementation for a better integration of the African needs in the international agenda for personalised medicine.
We are pleased to announce the first ECRIN CTU day will be held from 10:00-13:00 CET 26 November 2021 online.
Audience: Open to all ECRIN national partners CTUs and affiliated institutions that can provide services to multinational clinical trials.
EULAC PerMed is hosting its next webinar on In-silico models and personalised medicine on Thursday, 25 November 2021 at 15:00CET/10:00BRT.
